PCSK6 and atherosclerosis: Some of these causal gene candidates have potential opportunities for drug target repurposing to treat atherosclerotic vascular disease, including PCSK6. Ultimately, this study provides a better understanding of biological pathways underlying atherosclerosis to inform future therapeutic development.